Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders.
ACS Medicinal Chemistry Letters August 22, 2022 DOI: 10.1021/acsmedchemlett.2c00354 (opens in new tab)
Study at a glance
AI-extracted from the abstractAbstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTApplication of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological DisordersRobert B. Kargbo*Robert B. KargboUsona Institute, Fitchburg, Wisconsin 53711-5300, United States*E-mail: [email protected]More by Robert B. Kargbohttps://orcid.org/0000-0002-5539-6343Cite this: ACS Med. Chem. Lett. 2022, 13, 9, 1402–1404Publication Date (Web):August 22, 2022Publication History Received30 July 2022Published online22 August 2022Published inissue 8 September 2022https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00354https://doi.org/10.1021/acsmedchemlett.2c00354editorialACS PublicationsCopyright © Published 2022 by American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views3470Altmetric-Citations3LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (1 MB) Get e-AlertscloseSUBJECTS:Agonists,Anatomy,Diseases and disorders,Hydrogen isotopes,Receptors Get e-Alerts
Citations in the library
Cited by 4
- Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action. Journal of Neuroscience November 8, 2023
- Discovery and In Vitro Characterization of SPL028: Deuterated N,N-Dimethyltryptamine. ACS Medicinal Chemistry Letters September 14, 2023
- Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders. ACS Medicinal Chemistry Letters April 13, 2023
- Phenethylaminylation: Preliminary In Vitro Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model Compound. bioRxiv : the preprint server for biology February 17, 2025
Cites 6
- The promises and perils of psychedelic pharmacology for psychiatry. Nature Reviews Drug Discovery June 1, 2022
- Chronic, Intermittent Microdoses of the Psychedelic N , N -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents ACS Chemical Neuroscience March 4, 2019
- Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT) ACS Chemical Neuroscience July 23, 2018
- Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT Psychopharmacology January 22, 2022
- N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine Human Psychopharmacology: Clinical and Experimental February 17, 2022
and 1 more in the library